Sotera Health Company (SHC) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sotera Health Company  (NASDAQ: SHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Sotera Health's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sotera Health's ROI in the third quarter of 2026?
Sotera Health Company achieved a return on average invested assets (ROI) of 5.65 % in its third quarter of 2026, this is above SHC's average return on investment of 0.23%.
Sotera Health Companys investments during the 12 months ending in the third quarter of 2026 are valued at $3 billion

ROI has improved compared to 5.42% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 141 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1024 to 1765.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 5.27 % 3.3 % 3.13 % 1.46 % 0.15 %
Y / Y Net Income Change TTM 212.98 % 580.51 % 633.44 % 165.85 % 226.07 %
Investment (TTM) in Millions 3,164 3,076 3,028 3,014 2,944
Return On Investment (TTM) 5.65 % 5.42 % 3.94 % 2.64 % 1.9 %
SHC's Overall Ranking # 1765 # 1024 # 1369 # 1679 #
Seq. Investment Change TTM 1.82 % 0.88 % 1.33 % 1.14 % -0.08 %
Seq. Net Income Change TTM 6.11 % 38.78 % 51.12 % 40.64 % 130.72 %
Net Income (TTM) in Millions 173 163 118 78 55

SHC Company Profile >> Back to SHC Roi Comparisons >> See Annual SHC Return On Investment



Return On Investment SHC's Ranking
Within: No.
Industry # 18
Sector # 142
Overall # 1765

Return On Investment Statistics
High Average Low
5.21 %
0.23 %
-10.99 %
(Jun 30 2026)   (Sep 30 2023)







Financial Statements
Sotera Health's III. Quarter Investments $ 3,164 Millions SHC's Balance sheet
Sotera Health's III. Quarter Income $ 58 Millions Quarterly SHC's Income Statement
SHC's Income by Division See SHC's Income by Division


SHC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 3,014 2,881 2,900 2,326 2,628
Y / Y Investment Growth 4.62 % -0.66 % 24.66 % -11.5 % -
Net Income in Millions 78 44 51 -234 117
Y / Y Net Income Growth 75.57 % -13.58 % - - -
Annual Return On Investment 2.59 % 1.54 % 1.77 % -10.04 % 4.46 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 2.59 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SHC's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SHC's Competitors
Subscribers only: Roi for Sotera Health's Suppliers
Subscribers only: Return On Investment for SHC's Customers

Other Ratios
SHC's Roa SHC's Inventory Turnover Ratio SHC's Growth Rates SHC's Dividend Statistics
SHC's Profitability Ratios SHC's Asset Turnover Ratio SHC's Dividend Growth
SHC's Roe SHC's Valuation Ratios SHC's Financial Strength Ratios SHC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %

Date modified: 2026-11-06T13:04:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.